Sars-Cov-2 Spike Glycoprotein S1 (Derived from SF9 cell line)
|Amount :||50 µg|
|Purification :||Protein is >85% pure as determined SDS-PAGE.|
|Content :||CoV-2 S1 protein solution is supplied in DPBS.|
|Storage condition :||Store at -20°C.|
|AA sequence :||The Sf9 derived recombinant protein contains the Coronavirus 2019 CoV-2 Spike Glycoprotein S1, Wuhan-Hu-1 strain, amino acids 1-674 fused to His tag at C-terminal.|
|Alternative Name :||Coronavirus 2019 CoV-2 Spike Glycoprotein S1 (SF9 cell line)|
Source: Sf9, derived from Sf9 cells. A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019. The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2) in humans. While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.